Invention Grant
- Patent Title: 2-aryl-4-quinazolinones and their pharmaceutical compositions
- Patent Title (中): 2-芳基-4-喹唑啉酮及其药物组合物
-
Application No.: US13277520Application Date: 2011-10-20
-
Publication No.: US08710064B2Publication Date: 2014-04-29
- Inventor: Mann-Jen Hour , Po-Wu Gean , Sheng-Chu Kuo , Hong-Zin Lee , Jai-Sing Yang , Li-Chen Chou , Tai-Lin Chen , Yang-Chang Wu
- Applicant: Mann-Jen Hour , Po-Wu Gean , Sheng-Chu Kuo , Hong-Zin Lee , Jai-Sing Yang , Li-Chen Chou , Tai-Lin Chen , Yang-Chang Wu
- Applicant Address: TW Taichung
- Assignee: China Medical University
- Current Assignee: China Medical University
- Current Assignee Address: TW Taichung
- Agency: Fishman & Associates, LLC.
- Main IPC: A61K31/517
- IPC: A61K31/517

Abstract:
Provided is a compound of the formula I or a pharmaceutically acceptable salt, solvate or stereoisomer thereof: wherein Ar represents R5, R6, R7, R8, R1′, R2′, R3′, R4′, R5′, R6′, R7′, R8′ independently represent H, OH, F, Cl, Br, C1 to C6 alkyl group, C1 to C6 alkoxy group, C2 to C6 alkenyl group, C2 to C6 alkenoxy group, C2 to C6 alkynyl group, C2 to C6 alkynoxy group, amine group, mono- or di-substituted amino group, cyclic C1 to C5 alkylamino group, imidazolyl group, morpholino group, piperazinyl group, optionally substituted with one or more hydroxy or halo; and X represents NH, O or S. The present invention also provides a composition comprising the compound of formula I. The compound and the composition in accordance with the present invention are effective on treating or alleviating a disease or disorder, such as malignant glioma.
Public/Granted literature
- US20130102602A1 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions Public/Granted day:2013-04-25
Information query
IPC分类: